arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2010.09898q-bio.CB
收藏

埃博拉病毒体外复制动力学的定量研究

Quantification of Ebola virus replication kinetics in vitro

Laura E. Liao, Jonathan Carruthers, Sophie J. Smither, CL4 Virology Team, Simon A. Weller, Diane Williamson, Thomas R. Laws, Isabel Garcia-Dorival, Julian Hisco… 展开作者

Laura E. Liao, Jonathan Carruthers, Sophie J. Smither, CL4 Virology Team, Simon A. Weller, Diane Williamson, Thomas R. Laws, Isabel Garcia-Dorival, Julian Hiscox, Benjamin P. Holder, Catherine A. A. Beauchemin, Alan S. Perelson, Martin Lopez-Garcia, Grant Lythe, John Barr, Carmen Molina-Paris

AI总结:

本文通过体外实验数据与贝叶斯推断,定量刻画了埃博拉病毒感染周期中隐蔽期分布和病毒失活速率,为缺陷干扰颗粒共感染建模提供基础。

摘要:

数学建模已成功用于对许多病毒感染进行定量描述,但对于需要在生物安全4级设施中进行实验的埃博拉病毒而言,建模可以发挥关键作用。埃博拉建模工作主要集中于体内病毒动力学,例如在动物模型中,以辅助抗病毒药物和疫苗的开发。但迄今为止,这些研究尚未给出感染周期的详细规范,而这一规范可以为病毒动力学提供基础性描述,从而加深对其临床表现的理解。在本研究中,我们获得了埃博拉病毒体外感染的多样化实验数据集,然后利用贝叶斯推断方法完整识别病毒感染数学模型的参数。我们的结果揭示了受感染细胞处于隐蔽期(即从感染到开始产生病毒之间的时期)的时间分布,以及感染性病毒粒子失去感染力的速率。我们建议这些结果可用于未来描述与缺陷干扰颗粒共感染的模型,缺陷干扰颗粒是一种新兴的替代疗法。

英文摘要:

Mathematical modelling has successfully been used to provide quantitative descriptions of many viral infections, but for the Ebola virus, which requires biosafety level 4 facilities for experimentation, modelling can play a crucial role. Ebola modelling efforts have primarily focused on in vivo virus kinetics, e.g., in animal models, to aid the development of antivirals and vaccines. But, thus far, these studies have not yielded a detailed specification of the infection cycle, which could provide a foundational description of the virus kinetics and thus a deeper understanding of their clinical manifestation. Here, we obtain a diverse experimental data set of the Ebola infection in vitro, and then make use of Bayesian inference methods to fully identify parameters in a mathematical model of the infection. Our results provide insights into the distribution of time an infected cell spends in the eclipse phase (the period between infection and the start of virus production), as well as the rate at which infectious virions lose infectivity. We suggest how these results can be used in future models to describe co-infection with defective interfering particles, which are an emerging alternative therapeutic.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑